TransMedics Group, Inc. Common Stock (TMDX)

TransMedics receives full FDA IDE approval for its next-generation OCS Heart ENHANCE trial, signaling a significant advancement in organ transplant technology.

About TransMedics Group, Inc. Common Stock

TransMedics Group, Inc. is a healthcare company focused on organ transplant technology.
TransMedics Group, Inc. Common Stock uses the ticker $TMDX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

TransMedics Group, Inc. Common Stock (TMDX) social dominance hit [-----] which is 104% higher than it's daily average.
TransMedics Group, Inc. Common Stock (TMDX) social dominance near a 52-week high at [-----].
TransMedics Group, Inc. Common Stock (TMDX) social dominance is up 283.25% from the previous [--] months.
TransMedics Group, Inc. Common Stock (TMDX) creators is up 17.93% from the previous week.
TransMedics Group, Inc. Common Stock (TMDX) engagements is up 89.49% from the previous week.
TransMedics Group, Inc. Common Stock (TMDX) mentions is up 65.92% from the previous week.
TransMedics Group, Inc. Common Stock (TMDX) posts created is up 196.46% from the previous week.

Price: $129.80

Price 24-Hour Time-Series Raw Data
The stock price is experiencing a rebound, hitting a 52-week high supported by positive sentiment from insider buying and robust social engagement, despite a recent dip attributed to competitor news. Recent posts highlight strong revenue figures and analyst targets suggesting further upside.

24-Hour: 1.84% 7-Day: -4.19% 30-Day: -9.44%

1-Year High: $150.40 on 2025-12-01
1-Year Low: $64.40 on 2025-03-13

AltRank: [--]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
TransMedics Group, Inc. Common Stock (TMDX) is currently AltRank #72 based on combined combined social and market metrics Daily Average: [--]
[--] Week: [--] [----]
[--] Month: [--] +49
[--] Months: [--] +29
[--] Year: [--] [----]
1-Year High: [-----] on 2025-07-13
1-Year Low: [--] on 2025-05-11

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-04-24
1-Year Low: [--] on 2025-12-09

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-------]
[--] Week: [-------] +89%
[--] Month: [---------] -50%
[--] Months: [----------] -23%
[--] Year: [----------] -26%
1-Year High: [-------] on 2025-07-30
1-Year Low: [------] on 2025-12-16

Engagements by network (24h): TikTok: [--] Reddit: [--] News: [-----] YouTube: [---] Instagram: [-----] X: [------]

Mentions: [-----] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [---]
[--] Week: [-----] +66%
[--] Month: [-----] +4.60%
[--] Months: [------] +59%
[--] Year: [------] +167%
1-Year High: [-----] on 2025-07-31
1-Year Low: [---] on 2025-12-07

Mentions by network (24h): TikTok: [--] Reddit: [--] News: [--] YouTube: [--] Instagram: [--] X: [-----]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning TransMedics Group, Inc. Common Stock (TMDX) in the last [--] hours which is up 6.20% from [---] in the previous [--] hours Daily Average: [---]
[--] Week: [---] +18%
[--] Month: [---] -15%
[--] Months: [-----] -28%
[--] Year: [-----] +28%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-06

The most influential creators that mention TransMedics Group, Inc. Common Stock in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@growthrapidly	[--]	[------]	[--]	[------]
@Cry_ptosurff	[--]	[-----]	[---]	[-----]
@kimsbinvesting	[--]	[------]	[--]	[-----]
@KyleAdamsStocks	[--]	[------]	[--]	[-----]
@MrGeorge7n8	[--]	[-----]	[---]	[-----]
@mmonis	[--]	[------]	[--]	[-----]
@TheRayMyers	[--]	[------]	[--]	[-----]
@SingularityRes	[--]	[------]	[--]	[-----]
@Onlytrenchesboy	[--]	[---]	[--]	[-----]
@kode_lyoko39	[--]	[--]	[--]	[-----]

Sentiment: 89%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 89%
Daily Average: 86%
[--] Week: 93% +2%
[--] Month: 87% +5%
[--] Months: 87% -3%
[--] Year: 87% +8%
1-Year High: 96% on 2025-06-14
1-Year Low: 64% on 2025-03-17

Most Supportive Themes:

Positive Analyst Ratings and Insider Buying: (40%) Analysts and insiders are showing confidence in the company's future, contributing to positive sentiment.
Strong Social Engagement and Growth: (30%) Increased activity and interest on social media platforms indicate growing investor attention.
Company Performance and Guidance: (20%) Positive outlook on revenue growth and future guidance are boosting investor confidence.

Most Critical Themes:

Competition Concerns: (10%) Potential market share erosion due to competitors is a minor concern.

Social Dominance: 0.07%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.07%
Daily Average: 0.074%
[--] Week: 0.15% +0.108%
[--] Month: 0.151% +0.084%
[--] Months: 0.151% +0.043%
[--] Year: 0.151% +0.034%
1-Year High: 0.153% on 2025-03-01
1-Year Low: 0.024% on 2025-12-16

Market Dominance: 0.00503%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00503%
Daily Average: 0%
1-Year High: 0.085% on 2025-03-31
1-Year Low: 0.00318% on 2025-03-06

Market Cap: $4,437,194,358

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $4,437,194,358
Daily Average: $3,903,176,589
[--] Week: $4,437,194,358 -4.20%
[--] Month: $4,437,194,358 -9.40%
[--] Months: $4,437,194,358 +6.80%
[--] Year: $4,437,194,358 +83%
1-Year High: $5,140,501,967 on 2025-12-01
1-Year Low: $2,166,173,059 on 2025-03-13

Top TransMedics Group, Inc. Common Stock News

Top news links shared on social in the last [--] hours

Showing a maximum of [--] news posts without a LunarCrush subscription.

"TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial TransMedics Group Inc. ("TransMedics") (Nasdaq: TMDX) a medical technology company that is transforming organ transplant therapy for patients with end-stage lung heart and liver failure today announced that the U.S. Food and Drug Administration (FDA) has granted full approval of its Investigational Device Exemption (IDE) for the Next-Generation OCS ENHANCE Heart trial. This follows full FDA approval of the company"
News Link @YahooFinance 2026-02-09T13:12Z 2M followers, [----] engagements

Top TransMedics Group, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"#SIREN/USDT (Pair) LONG📈 Max leverage: 50X ENTRY: [-------] Targets: TP1. 🎯 [-------] TP2. 🎯 [-------] TP3. 🎯 [-------] TP4. 🎯 [-------] TP5. 🎯 [-------] ⛔StopLoss: [-------] Signals Group: $EOSE $OSCR $TTD $DUOL $APP $ALAB $TMDX $BTC $ETH $GUN $FUN https://t.me/+pJ1LI5Z3uOc0NTNk https://t.me/+pJ1LI5Z3uOc0NTNk"
X Link @kode_lyoko39 2026-02-16T09:36Z [--] followers, [---] engagements

"COIN: #SIREN/USDT ENTRY: [-------] LEVERAGE: 50X TARGET 🎯 💰0.14151 💰0.14485 💰0.14819 💰0.15138 💰0.15478 ⛔ STOP LOSS : [-------] Signals Group: $EOSE $OSCR $TTD $DUOL $APP $ALAB $TMDX $BTC $ETH $GUN $FUN $W $RARE $RATS $ADA $XRP $SOL $MLN https://t.me/+pJ1LI5Z3uOc0NTNk https://t.me/+pJ1LI5Z3uOc0NTNk"
X Link @kode_lyoko39 2026-02-16T09:30Z [--] followers, [---] engagements

"$EUL LONG Im waiting for the final upward impulse then Ill fully close my position and flip to short. $EOSE $OSCR $TTD $DUOL $APP $ALAB $TMDX #BNB #Bitcoin #Crypto $BTC #ETH https://t.me/+ICCuPiEZB0U0MDkx https://t.me/+ICCuPiEZB0U0MDkx"
X Link @Lucas_J30 2026-02-16T06:59Z [---] followers, [---] engagements

"Binance Futures #INIT/USDT All take-profit targets achieved 😎 Profit: 1372.4050% 📈 Period: [--] Hours [--] Minutes $EOSE $OSCR $TTD $DUOL $APP $ALAB $TMDX #BNB #Bitcoin #Crypto $BTC #ETH https://t.me/+ICCuPiEZB0U0MDkx https://t.me/+ICCuPiEZB0U0MDkx"
X Link @Lucas_J30 2026-02-16T06:56Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing